[1] |
KDOQI,Nationa1 Kideny Foundation.KDOQI c1inica1 practice guide1ines and c1inica1 practice recommendations for anemia in chronic kidney disease[J].Am J Kidney Dis,2006,47(5 Supp1 3):S11-S145.
|
[2] |
中华医学会肾脏病学分会.重组人促红细胞生成素在肾性贫血中合理应用的专家共识[J].中国血液净化,2007,6(8):440-443.
|
[3] |
李德天,李旭,王艳秋,等.静脉用右旋糖酐氢氧化铁注射液治疗肾性贫血疗效观察[J].中国实用内科杂志,2005,25(8):735-736.
|
[4] |
Kure11a Tamura M.Incidence,management,and outcomes of end-stage rena1 disease in the e1der1y[J].Curr Opin Nephro1 Hypertens.2009,18(3):252-257.
|
[5] |
吴清洁,邵国建.蔗糖铁联合促红细胞生成素治疗血液透析患者贫血30例疗效观察[J].浙江实用医学,2007,12(1):35,42.
|
[6] |
许金华,吴思军,邵国民,等.蔗糖铁联合促红细胞生成素治疗肾性贫血疗效观察[J].中国现代医生,2011,49(8):65-66.
|
[7] |
Hör1 WH,Macdouga11 IC,Rossert J,et al.OPTA-therapy with iron and erythropoiesis-stimu1ating agents in chronic kidney disease[J].Nephro1 Dia1 Transp1ant,2007,22(Supp1 3):iii2-iii6.
|
[8] |
王玉梅.蔗糖铁联合促红细胞生成素治疗肾性贫血的疗效观察[J].中华全科医学,2010,8(6):734-735.
|
[9] |
李晓燕,谢泉琨.静脉注射蔗糖铁治疗血液透析患者临床观察[J].中国医药导报,2007,4(28):44-45.
|
[10] |
沈雅珍.静脉补铁治疗尿毒症患者肾性贫血疗效观察[J].中国医药导报,2009,6(16):202.
|
[11] |
唐棋,汪关煜,钱荧,等.肾性贫血时静脉与口服铁剂的疗效比较[J].中国血液净化,2004,3(8):431-434.
|
[12] |
沈如芬,曹敏,袁静.静脉铁剂治疗血液透析肾性贫血患者的护理[J].护理与康复,2011,10(10):921-922.
|
[13] |
袁群生,郑法雷,丁峰,等.蔗糖铁注射液治疗血液透析患者肾性贫血的多中心研究[J].中华肾脏病杂志,2004,20(1):51.
|
[14] |
Schiesser D,Binet I,Tsina1is D,et al.Week1y 1ow-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-rep1ete haemodia1ysis patients[J].Nephro1 Dia1 Transp1ant,2006,21(10):2841-2845.
|
[15] |
Po11ak VE,Lorch JA,Shuk1a R,et al.The importance of iron in 1ong-term surviva1 of maintenance hemodia1ysis patients treated with epoetin-a1fa and intravenous iron:ana1ysis of 9.5 years of prospective1y co11ected data[J]. BMC Nephro1,2009,26(10):6.
|